Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127069961 | 12706996 | 1 | I | 20160806 | 20160816 | 20160901 | 20160901 | EXP | PHHY2016FR112737 | NOVARTIS | 83.46 | YR | F | Y | 60.00000 | KG | 20160901 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127069961 | 12706996 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, ONCE/SINGLE | 5 | MG | 16HL0104 | 21817 | 5 | MG | SOLUTION FOR INJECTION | 1X | |||
| 127069961 | 12706996 | 2 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 127069961 | 12706996 | 3 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Unknown | 1 G, TID | U | 0 | 1 | G | TID | ||||||
| 127069961 | 12706996 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 127069961 | 12706996 | 5 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 127069961 | 12706996 | 6 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | Unknown | U | 0 | ||||||||||
| 127069961 | 12706996 | 7 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127069961 | 12706996 | 1 | Osteoporosis |
| 127069961 | 12706996 | 2 | Product used for unknown indication |
| 127069961 | 12706996 | 3 | Product used for unknown indication |
| 127069961 | 12706996 | 4 | Product used for unknown indication |
| 127069961 | 12706996 | 5 | Product used for unknown indication |
| 127069961 | 12706996 | 6 | Product used for unknown indication |
| 127069961 | 12706996 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127069961 | 12706996 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127069961 | 12706996 | Arthralgia | |
| 127069961 | 12706996 | Asthenia | |
| 127069961 | 12706996 | Back pain | |
| 127069961 | 12706996 | Fatigue | |
| 127069961 | 12706996 | Headache | |
| 127069961 | 12706996 | Migraine | |
| 127069961 | 12706996 | Mood altered | |
| 127069961 | 12706996 | Musculoskeletal chest pain | |
| 127069961 | 12706996 | Nausea | |
| 127069961 | 12706996 | Neck pain | |
| 127069961 | 12706996 | Pain in extremity | |
| 127069961 | 12706996 | Rectal haemorrhage | |
| 127069961 | 12706996 | Rectal prolapse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127069961 | 12706996 | 1 | 20160805 | 20160805 | 0 |